Delivery Order SPE2DB22D3102-SPE2DB25FK9WE
Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 60 ml bottles of 6 mg/ml oseltamivir suspension. The contract has a ceiling value of $6,953.34 and a completion date of September 19, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical for the delivery of a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml Suspension in 60ml quantities, valued at $2,025.68, with an ultimate completion date of December 30, 2025. This contract is a firm fixed price delivery order with no set-aside designation, awarded competitively on December 29, 2025. The award is fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60 ml quantities, with a contract ceiling value of $1,564.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 23, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Oseltamivir 6 mg/mL suspension in 60 mL quantities, with a ceiling value of $2,301.69. This order, which is set to be completed by January 5, 2026, represents a firm fixed-price contract with no set-aside designation. The award was made competitively and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 60 ml bottles of 6 mg/ml oseltamivir suspension. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,302.24 and a completion date of March 13, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor, and the contract is associated with the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,408.32 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This contract, executed on December 11, 2025, with completion scheduled for December 12, 2025, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. The delivery location is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities, with a contract ceiling value of $1,450.25. This firm fixed-price delivery order, which has no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. The place of performance is AmerisourceBergen's corporate office...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,392.57 firm fixed-price delivery order is for the supply of Oseltamivir 6 mg/ml suspension (60 ml), a prescription antiviral medication. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of oseltamivir phosphate 75 mg capsules. The $1,116.37 firm fixed-price contract has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,885.41 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4567178204 - OSELTAMIVIR 6 MG/ML SUSPENSION 60ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FK9WEDelivery Order
This is a $1,453.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir 6 mg/mL suspension in 60 mL bottles. The contract has a completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 7/1/25, 6:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 2/6/25 |